These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 734003)

  • 1. Case conferences from Cornell. Case 2: Approaches to the treatment of the drug resistant schizophrenic patient.
    Psychiatr Q; 1978; 50(4):299-306. PubMed ID: 734003
    [No Abstract]   [Full Text] [Related]  

  • 2. The management of white certified schizophrenic patients in the community of the Witwatersrand.
    Pearlman T
    S Afr Med J; 1970 Oct; 44(41):1181-2. PubMed ID: 5497512
    [No Abstract]   [Full Text] [Related]  

  • 3. A study of the withdrawal of chlorpromazine or trifluoperazine in chronic schizophrenia.
    Morton MR
    Am J Psychiatry; 1968 May; 124(11):1585-8. PubMed ID: 4869439
    [No Abstract]   [Full Text] [Related]  

  • 4. A planned system of community care for schizophrenia in Great Britain.
    Imlah NW; Murphy KP
    Aust N Z J Psychiatry; 1976 Jun; 10(2):141-5. PubMed ID: 1067831
    [No Abstract]   [Full Text] [Related]  

  • 5. What are the needs of chronic mental patients?
    Peterson R
    Schizophr Bull; 1982; 8(4):610-6. PubMed ID: 7178847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double blind comparison of thiothixene and a trifluoperazine/chlorpromazine composite in the treatment of chronic schizophrenia.
    Knight RG; Harrison A
    N Z Med J; 1979 Apr; 89(634):302-4. PubMed ID: 377155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schizophrenia and social networks: ex-patients in the inner city.
    Cohen CI; Sokolovsky J
    Schizophr Bull; 1978; 4(4):546-60. PubMed ID: 734366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of treatment with an amino oxidase inhibitor on the excretion of bufotenin and the clinical symptoms in chronic schizophrenic patients.
    Heller B
    Int J Neuropsychiatry; 1966 Apr; 2(2):193-203. PubMed ID: 5959966
    [No Abstract]   [Full Text] [Related]  

  • 9. Coordinating mental health systems: a national and international perspective.
    Gittelman M
    Am J Public Health; 1974 May; 64(5):496-500. PubMed ID: 4361844
    [No Abstract]   [Full Text] [Related]  

  • 10. Ataractic drugs versus ECT in schizophrenia.
    Spensley J
    Am J Psychiatry; 1973 Oct; 130(10):1162-3. PubMed ID: 4728918
    [No Abstract]   [Full Text] [Related]  

  • 11. Approaches to establishing community services for the mentally disabled.
    Arce AA
    Psychiatr Q; 1978; 50(4):264-8. PubMed ID: 733997
    [No Abstract]   [Full Text] [Related]  

  • 12. The cost of schizophrenia.
    Gunderson JG; Mosher LR
    Am J Psychiatry; 1975 Sep; 132(9):901-6. PubMed ID: 168788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolixin enanthate and thorazine-stelazine regimens in the treatment of schizophrenic patients. An experimental evaluation.
    DeWolfe AS; Barrell RP; London L; Spaner FE
    Psychosomatics; 1971; 12(3):186-90. PubMed ID: 4950862
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of chlorpromazine and trifluoperazine on the activity of chronic schizophrenics.
    Jones IH; Pikler N
    Br J Psychiatry; 1971 Nov; 119(552):545-6. PubMed ID: 4944663
    [No Abstract]   [Full Text] [Related]  

  • 15. Patient subgroups in state psychiatric hospitals and implications for administration.
    Holohean EJ; Banks SM; Maddy BA
    Hosp Community Psychiatry; 1993 Oct; 44(10):1002-4. PubMed ID: 8225265
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute paranoid schizophrenia. (Treatment with chlorpromazine, trifluoperazine and placebo).
    Reardon JD; Abrams S
    Dis Nerv Syst; 1966 Apr; 27(4):265-70. PubMed ID: 5936140
    [No Abstract]   [Full Text] [Related]  

  • 17. Are antipsychotic drugs interchangeable?
    Gardos G
    J Nerv Ment Dis; 1974 Nov; 159(5):343-8. PubMed ID: 4612111
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of loxapine in the treatment of paranoid schizophrenia.
    Bishop MP; Simpson GM; Dunnett CW; Kiltie H
    Psychopharmacology (Berl); 1977 Jan; 51(2):107-15. PubMed ID: 14350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of triphthazine in the treatment of mentae disorders].
    Gurowitsch IJ; Awruzki GJ
    Psychiatr Neurol Med Psychol (Leipz); 1975 May; 27(5):284-91. PubMed ID: 812131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research on the psychosocial treatment of schizophrenia: a summary report.
    Mosher LR; Keith SJ
    Am J Psychiatry; 1979 May; 136(5):623-31. PubMed ID: 219718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.